MRC-Holland MLPA. Description version 15;

Size: px
Start display at page:

Download "MRC-Holland MLPA. Description version 15;"

Transcription

1 probemix P036-E1 HUMAN TELOMERE-3 Lot E1-0910, E1-1208, E As compared to version D2 (lot D2-0408), the probes for 1p and 4q have been replaced. Approximately 3-8% of all cases of mental retardation is caused by aberrant copy numbers of subtelomeric regions, e.g. due to unbalanced translocations. This P036-E1 human telomere-3 probemix contains one MLPA probe for each subtelomeric region and is designed to detect deletions/duplications of these subtelomeric regions. For the acrocentric chromosomes 13, 14, 15, 21 and 22, which contain primarily repeat sequences on their entire p-arms, we included a probe on the q arm, close to the centromere. Due to an increased frequency of copy number variable (cnv) regions close to the telomeres in healthy individuals, we strongly recommend to further investigate any abnormality detected, e.g. using our telomere follow up probemixes and by analysis of parental samples. More information is available on pages 4-7. At the p-telomeric ends of the X and Y chromosomes a region of approximately 2500 kb of DNA is identical in both sex chromosomes: the pseudoautosomal region 1, or PAR1. Similarly, the PAR2 region of approximately 800 kb at the q-telomeric ends is also identical for chromosome X and Y. The probes in these PAR regions will therefore show identical copy numbers in most males and females. Also included are two small synthetic MLPA probes for non-telomeric Y-chromosome specific sequences. This SALSA probemix is designed to detect deletions/duplications of one or more genes at the telomere ends in a human DNA sample. Heterozygous deletions of probe recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic. Users should always verify the latest scientific literature when interpreting their findings. The Database of Genomic Variants can be useful to verify whether copy number changes occur in normal individuals: A website with useful information on MLPA and FISH probe locations is SALSA probemixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the SALSA test probemixes and reagents includes a limited license to use these products for research purposes. The use of a SALSA probemix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). Related SALSA probemixes More probemixes for specific subtelomere analysis are available (follow-up probemixes); see page 4-7. P070 Human telomere-5: contains a probe for every human subtelomere. Should be used together with the probemix P036 Human telomere-3. P069 Human telomere-4: Identical to P070 Human telomere-5, but does not contain probes for the acrocentric chromosome arms 13p, 14p, 15p, 21p and 22p. P245 Microdeletion: probes for 21 different microdeletion syndromes; can be used for primary screening of microdeletion syndromes. P064 MR-1/P096 MR-2: contains probes for several microdeletion syndromes P106 MRX: X-linked mental retardation More probemixes are available for specific syndromes, including RETT(-like) syndrome, DiGeorge, Prader- Willi/Angelman, Lissencephaly, Canavan, Williams syndrome and many more. Please see our website. More information Website : info@mlpa.com (information & technical questions); order@mlpa.com (orders) Mail : bv; Willem Schoutenstraat 6, 1057 DN Amsterdam, the Netherlands SALSA P036 Human telomere-3 Page 1 of 9

2 References of SALSA probemixes P036 & P070 (P069) Broad Telomere Screening A PubMed search on MLPA and telomere will provide more than 30 references. Ahn J. et al. (2007). Detection of subtelomere imbalance using MLPA: validation, development of an analysis protocol, and application in a diagnostic centre. BMC Medical Genetics Mar 5;8(1):9. Bruno D.L. (2006). High-throughput analysis of chromosome abnormality in spontaneous miscarriage using an MLPA subtelomere assay with an ancillary FISH test for polyploidy. Am J Med Genet A Dec 15;140(24): Darnfors C et al. (2005). High-resolution analysis of the subtelomeric regions of human embryonic stem cells. Stem Cells.; 23(4): Erjavec-Skerget A. (2006). Subtelomeric chromosome rearrangements in children with idiopathic mental retardation: applicability of three molecular-cytogenetic methods. Croat Med J Dec;47(6): Kirchhoff M. et al. (2005). Investigation of patients with mental retardation and dysmorphic features using comparative genomic hybridization and subtelomeric multiplex ligation dependent probe amplification. Am J Med Genet A Dec 15;139(3): Koolen DA et al. (2004). Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet.; 41(12): Lam AC et al. (2006) High rate of detection of subtelomeric aberration by using combined MLPA and subtelomeric FISH approach in patients with moderate to severe mental retardation. Clin Biochem. 39(3): Monfort S. et al. (2006). Evaluation of MLPA for the detection of cryptic subtelomeric rearrangements. J Lab Clin Med Jun;147(6): Northrop, EL et al. (2005). Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay. Hum. Mutat. 26 (5): Palomares, M. et al. (2006). MLPA vs multiprobe FISH: comparison of two methods for the screening of subtelomeric rearrangements in 50 patients with idiopathic mental retardation. Clin Genet Mar;69(3): Rooms, L. et al. (2006). Multiplex ligation-dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics. Clin Genet Jan; 69(1): Data analysis The P036-E1 Telomere-3 probemix contains 46 MLPA probes with amplification products between 130 and 483 nt. In addition, it contains 10 control fragments generating amplification products smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at nt, three DNA denaturation control fragments (D-fragments) at nt, one X-chromosome specific fragment at 100 nt and two chromosome Y- specific fragments at 105 & 118 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this probemix can be normalised intra-sample by dividing the peak area of each amplification product by the combined peak area of all peaks in that sample (global normalisation). Secondly, inter-sample normalisation can be achieved by dividing the intra-normalised probe ratio in a sample by the average intra-normalised probe ratio of all reference samples. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. For broad telomere screening it is recommended to use SALSA probemixes P036 and/or P070 Human Telomere. Confirmation of most deletions can be done by one of the SALSA telomere follow-up probemixes (see page 5) or by another method, such as FISH, LR-PCR, southern blotting and sequencing. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website Many copy number alterations in healthy individuals are described in the database of genomic variants: For example, a duplication of a complete gene might not be pathogenic, while a partial duplication or a deletion may result in disease. For some genes, certain in-frame deletions may result in a very mild, or no disease. Copy number changes of reference probes are unlikely to be the cause of the condition tested for. Users should always verify the latest scientific literature when interpreting their findings. This probemix was developed at. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA P036 Human telomere-3 Page 2 of 9

3 Table 1. P036-E1 Human Telomere-3 probemix Length Chromosomal Gene detected (nt) position probe MapView build 36 position Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 118 Y-fragment: Specific for the Y chromosome 130 ± 1p TNFRSF L p ACP L p CHL L p PIGG (FLJ20265) L p PDCD L p IRF L p ADAP1 (CENTA1) L p FBXO L p DMRT L p DIP2C (KIAA0934) L p RIC8A (RIC-8) L ± 12p SLC6A L ± 13q-cen PSPC L (Acrocentric chromosome) q-cen CCNB1IP1 (HEI10) L (Acrocentric chromosome) q-cen MKRN L (Acrocentric chromosome) p POLR3K L p RPH3AL L p USP L ± 19p CDC L p SOX L q-cen RBM L (Acrocentric chromosome) q-cen BID L (Acrocentric chromosome) 298 Xp/Yp (PAR1) SHOX L01331 X/Y (PAR1 region) 307 1q SH3BP5L (KIAA1720) L (0.2 Mb from telomere) 313 2q CAPN L (1.6 Mb from telomere) 322 3q BDH L (0.7 Mb from telomere) 330 4q TRIML L (2.0 Mb from telomere) 337 5q GNB2L L (0.2 Mb from telomere) 346 6q PSMB L (0.5 Mb from telomere) 355 7q VIPR L (0.3 Mb from telomere) 361 8q ZC3H3 (KIAA0150) L (1.6 Mb from telomere) 372 9q EHMT L (0.2 Mb from telomere) q PAOX (PAO) L (0.2 Mb from telomere) q NCAPD3 (KIAA0056) L (1.2 Mb from telomere) q ZNF L (0.2 Mb from telomere) q F L (1.3 Mb from telomere) 411 ± 14q MTA L (1.3 Mb from telomere) 418 ± 15q ALDH1A L (1.0 Mb from telomere) q GAS8 (GAS11) L (0.2 Mb from telomere) q TBCD L (0.5 Mb from telomere) q RBFA (C18orf22) L (0.2 Mb from telomere) 450 ± 19q CHMP2A (BC-2) L (0.9 Mb from telomere) 458 ± 20q OPRL L (0.2 Mb from telomere) q PRMT2 (HMT1) L (0.1 Mb from telomere) q RABL2B L (0.1 Mb from telomere) 483 Xq/Yq (PAR2) VAMP7 (SYBL1) L02150 X/Y (PAR2; 0.1 Mb from telom.) Many notes on individual probes are present on page 7 and 8. New in version E1 (from lot E onwards) + The 13, 14, 15, 21 & 22 q-cen probes target the q arm close to the centromer (acrocentric chromosomes). ± This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. Complete probe sequences are available on request: info@mlpa.com. Please notify us of any mistakes and of interesting findings: info@mlpa.com. SALSA P036 Human telomere-3 Page 3 of 9

4 Finding the genetic cause of mental retardation with MLPA The number of genes whose defect can result in mental retardation is large. In some cases, particular phenotypic features suggest the involvement of a specific gene or chromosomal region. Numerous SALSA MLPA probemixes are available to find the cause of mental retardation with distinct syndromic features, such as RETT, Sotos and Prader-Willi/Angelman syndrome. For patients suffering from non-syndromic mental retardation, the genetic cause is found only in a minority of cases. Usually, primary screening of these patients is done by karyotyping or G-banding. When no abnormality is detected by these methods, we suggest screening patients with the following probemixes: SALSA probemix P245 Microdeletion syndromes for 21 distinct microdeletion syndromes SALSA probemixes P036 Human telomere-3 and P070 Human telomere-5 for broad telomere screening Figure 1: Flowchart suggesting how to test a patient with mental retardation lacking clear syndromic features. SALSA probemix P245 Microdeletion syndromes P245 Microdeletion syndromes contains probes for 21 different microdeletion syndromes causing mental retardation. In case an abnormality is found with SALSA probemix P245 Microdeletion syndromes, we recommend further investigation using one of the microdeletion follow-up probemixes. See the P245 Microdeletion syndromes product description for details. SALSA probemix P036 Human telomere-3 and P070 Human telomere-5 Studies have indicated that 3-8% of all mental retardation cases are caused by aberrant copy numbers of subtelomeric regions (see references on p.2). SALSA probemixes P036 Human telomere-3 and P070 Human telomere-5 both contain one probe for each subtelomere and detect deletions/duplications in the subtelomeric regions. It is recommended to use both probemixes together to maximise the detection rate. Most probes in the P036 and P070 probemixes target well-characterised genes adjacent to the telomere. An exception is made for the p-arms of chromosomes 13, 14, 15, 21 and 22 as these are covered by over 10 Mb of repeat sequences. Here, the p probes recognise one of the first genes on the q arm, close to centromere. SALSA probemix P069 Human telomere-4 does not contain probes for these acrocentric arms. SALSA P036 Human telomere-3 Page 4 of 9

5 The detection of abnormal copy numbers in subtelomeric regions is complicated. Subtelomeric copy number changes can also occur in unaffected individuals and the effect of a deletion or duplication will depend on the genes involved. A considerable number of abnormalities detected by a single probe may not have a phenotypic effect but can be due to a rare polymorphism or a copy number change which is also present in one of the parents. For some chromosome arms, even large subtelomeric deletions (>1 Mb) can be inherited without a phenotypic effect; see the notes on p. 6 & 7. Abnormalities detected by our subtelomere probemixes will therefore not always be the cause of the mental retardation. For all abnormalities detected, we strongly recommend testing parents to determine whether the copy number aberration in the patient is de novo. De novo deletions/duplications have a higher probability of being the cause of the mental retardation. The Database of Genomic Variants can be useful to verify whether copy number changes occur in normal individuals: For the reasons mentioned above, the development of a perfect MLPA assay for the detection of subtelomeric deletions and duplications is complicated. Genes that are located very close to the telomeres have a higher chance of being polymorphic in copy number (i.e. duplicated/deleted in a small percentage of unaffected individuals, sometimes only in certain populations), whereas situating probes at a larger distance from the telomeres may lead to false negatives. Based on feedback from customers, we will try to further improve our telomere probemixes. New versions are therefore expected in the future. Follow-up When used correctly, MLPA will exclude the presence of abnormal copy numbers of subtelomeric regions in the majority of samples. However, no method will be capable of detecting all chromosomal aberrations. MLPA will not detect inversions or balanced translocations. Frequent microdeletion syndromes can be detected with the P245 Microdeletion syndromes probemix, but many rare interstitial deletions will not. In case an abnormality is detected by the P036 and/or P070, there are two ways to confirm the result: 1. Confirmation by another method, such as FISH, LR-PCR, Southern blot and sequencing. 2. Using a SALSA telomere follow-up probemix. Follow-up probemixes contain more probes per telomere and are suitable to examine a specific region more closely. Using an MLPA follow-up probemix will enable you both to confirm the presence of the aberration and determine its size. More detailed subtelomeric analysis For a closer examination of samples in which aberrant copy numbers have been found, the following MLPA probemixes are available. Subtelomeric region Subtelomeric region probemix probemix 1p (36 probes) P147 1p36 1q (14 probes) P264 telo-9 2p (13 probes) P208 telo-6 2q (12 probes) P264 telo-9 3p (11 probes) P208 telo-6 3q (11 probes) P264 telo-9 4p (16 probes) P358 telo-15 4q (8 probes) P264 telo-9 5p (6 probes) P358 telo-15 5q (13 probes) P277 telo-10 6p (12 probes) P208 telo-6 6q (10 probes) P277 telo-10 7p (10 probes) P365 telo-14 7q (10 probes) P277 telo-10 8p (12 probes) P208 telo-6 8q (10 probes) P277 telo-10 9p (12 probes) P230 telo-7 9q (13 probes) P286 telo-11 10p (11 probes) P230 telo-7 10q (8 probes) P286 telo-11 11p (7 probes) P230 telo-7 11q (14 probes) P286 telo-11 12p (11 probes) P230 telo-7 12q (9 probes) P286 telo-11 13q-cen (7 probes) P358 telo-15 13q (12 probes) P291 telo-12 14q-cen (7 probes) P358 telo-15 14q (10 probes) P291 telo-12 15q-cen (3 probes) P365 telo-14 15q (10 probes) P291 telo-12 16p (8 probes) P365 telo-14 16q (10 probes) P291 telo-12 17p (15 probes) P249 telo-8 17q (10 probes) P320 telo-13 18p (8 probes) P249 telo-8 18q (10 probes) P320 telo-13 19p (9 probes) P249 telo-8 19q (8 probes) P320 telo-13 20p (13 probes) P249 telo-8 20q (7 probes) P320 telo-13 SALSA P036 Human telomere-3 Page 5 of 9

6 Subtelomeric region Subtelomeric region probemix probemix 21q-cen (4 probes) P365 telo-14 21q (9 probes) P365 telo-14 22q-cen (19 probes) P356 Chr. 22q 22q (17 probes) P356 Chr. 22q To make a more detailed screening of all chromosomes easier, an attractively-priced Telomere Follow-up Set containing 25 reactions of each of the 12 telomere follow-up probemixes is available for an introduction price of 1200 euro in It is also possible to order each follow-up probemix separately (25, 50 or 100 reactions). Important notes on specific telomeres Please inform us about any mistakes or interesting findings: info@mlpa.com. All complete probe sequences are available on request: info@mlpa.com. 1p: The P036-E probemix contains a new probe for 1p (TNFRSF4 gene). The 1p probe in P036-D (SCNN1D) gave variable results and the 1p probe in P036-B (CAB45) was found to be deleted or duplicated in some healthy families. The P069/P070 probe for 1p detects a sequence that has been found to be duplicated in a normal individual (K. Claes, Ghent). As deletions of this region may have consequences, we will not replace this probe. 2p: The P036 probe for 2p has been found to be deleted in several healthy persons in Nijmegen (E. Sistermans) and Maastricht. We do not know whether this is due to a polymorphism in the Dutch population. In case deletions in healthy persons also occur elsewhere, this probe will be replaced in the future. Please inform us on aberrant results. 3p: The P036/P069/P070 probes for 3p (CHL1 gene) were found to be duplicated in healthy parents (J. Wook Ahn, London and E. Sistermans, Nijmegen). In another family, a deletion of the P036 and P069- P070 probes for 3p was detected in a healthy parent (J. Wook Ahn, London). According to Dijkhuizen et al (2006; Am.J.Hum.Genet. 140A, ), defects in the more centromeric CNTN4 and CRBN genes might be more important for the 3p syndrome than CHL1 loss. 5p: The P036 probe for 5p was found to be duplicated in two healthy parents (F. Jehee, Sao Paulo). 9p: The P069/P070 probes for 9p (DOCK8 gene) were found to be duplicated in a healthy parent in four different families by J. Wook Ahn (London). In one other family, a deletion of this probe was detected in a healthy parent (same lab). 11p: The P036/P069/P070 probes for 11p detect sequences that have been found to be duplicated in sporadic cases in a normal individual (M. Palomares Bralo, Madrid). As deletions of this region might well have consequence, we will not replace this probe. 12p: The P036/P069/P070 probes detect sequences that were found to be duplicated in a healthy parent in one Brazilian family (F. Jehee, Sao Paulo). In two other families, a deletion of the P036 probe was detected in a healthy parent (same lab) while the P070 probe for 12p was normal. 13q-cen: This probe detects sequences on the q-arm, close to the centromere, as the p-arm of this chromosome does not contain well-characterised genes. 14q-cen: This probe detects sequences on the q-arm close to the centromere, as the p-arm of this chromosome does not contain well-characterised genes. 15q-cen: This probe detects sequences on the q-arm close to the centromere, as the p-arms do not contain well-characterised genes. The P036 probe for 15q-cen detects the MKRN3 gene (234 nt). This region is deleted in some Prader-Willi/Angelman syndrome patients. The PWS/AS critical region (SNRPN gene) is located at a distance of 1.3 Mb towards the q-telomere. We recommend the SALSA probemix ME028 Prader-Willi/Angelman for further characterisation of copy number changes of the MKRN3 region. 16p: In several Brazilian families a deletion of the P036 probe for 16p was detected in a healthy parent, while the P070 probe showed normal results (F. Jehee, Sao Paulo). 20p: The P036/P069/P070 probes for 20p detect sequences that have been found to be duplicated in sporadic cases in a normal individual (V. Biancalana; Strasbourg). As deletions of this region might have consequences, we will not replace this probe. 21q-cen: This probe detects sequences on the q-arm close to the centromere, as the p-arm of this chromosome does not contain well-characterised genes. 22q-cen: This probe detects sequences on the q-arm close to the centromere, as the p-arm of this chromosome does not contain well-characterised genes. SALSA P036 Human telomere-3 Page 6 of 9

7 3q: The P036 probe for 3q (BDH gene) was found to be duplicated in a healthy parent by E. Reyniers, Antwerp (confirmed by FISH). The P070/P069 probe for 3q, located 200 kb closer to the telomere, did not show this duplication. Apparently, copy number polymorphisms of the BDH gene region occur in healthy individuals. However, please note that a 3q29 microdeletion syndrome (due to an interstitial deletion) has been described (Willatt et al, J. Hum. Genet. 77: , 2005) and that the probe in the P036 probemix detects a sequence within this commonly deleted region. The 3q probe in P070 will not detect this microdeletion, as it detects a sequence located between the interstitial deletion and the telomere. 4q: The P036-E probemix contains a new probe for 4q. The 4q telomeric region is complicated and very few genes are present. The FRG1 gene is the only well-characterised gene in the terminal 2-3 Mb of 4q, but the FRG1-specific probes in P036-B, P036-C and P036-D were found to be unreliable due to the presence of population-specific SNPs in FRG1. The 4q probe in P036-E is located at larger distance from the telomere; we do not expect this to cause many false-negative results as deletions of the telomeric 2-3Mb region of 4q do not seem to cause any phenotypic effects (Shao, L. et al (2008) Am. J. Med. Genet.). 5q: The P036 probe for 5q was found to be influenced in one patient by a polymorphism in the first nucleotide after the ligation site by K. Franke (Dresden). Please report similar findings as probes influenced by polymorphisms will be replaced. The P036/P069/P070 probes for 5q detect sequences that have been found to be duplicated in sporadic cases in a normal individual (K. Mann, London, L. Rooms & S. Seneca, Antwerp). As deletions of this region may have consequences, we will not replace this probe. 12q: A Dutch lab detected a ZNF10 duplication in a healthy parent with both the P036 and P070. ZNF10 is described as variable in copy number (Database of Genomic Variants, 17q: A duplication of the P069/P070 probe was detected in a healthy parent (F. Jehee, Sao Paulo). 19q: The P036/P070 probe for 19q gave variable results in healthy controls (F. Grati, Italy, and J. W. Ahn, UK). 22q: The P070 probe for 22q was found to be deleted in one healthy parent (F. Jehee, Sao Paulo). The sequence detected by the P036 probe for 22q has only one mismatch with a related sequence on chromosome 2. This is sufficient to generate a chr. 22q specific MLPA signal. However, when this region is to be sequenced, primer design is complicated. Only 4 mismatches are present in the 350 nt region containing this probe sequence. The P188 probe set contains many probes close to the 22q13 telomere and can be used to confirm or further characterise 22q13 deletions. X, Y: The 298 & 483 probes in P036/P069/P070 detect sequences located on both X & Y chromosome close to the telomeres (PAR region) and will thus indicate the combined copy number of X and Y. Differences between P036-D and P036-E The 1p and 4q probes have been replaced. Differences between P036-B and P036-E 1. The CAB45 probe for 1p36 has been replaced in P036-E by a probe for the TNFRSF4 gene. 2. The FRG1 probe for 4q has been replaced in P036-E by a probe for the TRIML2 gene. 3. The P036-B probe for 9q has been replaced in P036-E by a probe for the EHMT1 gene. 4. The CYFIP1 probe for 15p in P036-B was located in a polymorphic region and has been replaced by a MKRN3 probe in P036-E. 5. The 379 nt probe for 10q and the 450 nt probe for 19q have been recloned and have higher signals in P036-E as compared to P036-B. Length of these probes has been slightly altered but the sequences detected have remained identical. 6. Extra control fragments specific for the X and Y-chromosome have been included at 100 and 105 nt. SALSA P036 Human telomere-3 Page 7 of 9

8 probemix P036-E1 sample picture D y e S i g n a l Size (nt) Figure 2. Capillary electrophoresis pattern from a sample of approximately 50 ng human male control DNA analysed with probemix P036-E1 Human Telomere-3 (lot E1-0910). The old MLPA buffer (replaced in December 2012) was used. Vials with the old MLPA buffer have a white label D y e S i g n a l Size (nt) Figure 3. Capillary electrophoresis pattern from a sample of approximately 50 ng human male control DNA analysed with probemix P036-E1 Human Telomere-3 (lot E1-0910). The new MLPA buffer (introduced in December 2012) was used. Vials with the new MLPA buffer have a yellow label. SALSA P036 Human telomere-3 Page 8 of 9

9 Implemented Changes compared to the previous product description version(s). Version 15 (48) - Warning added in Table 1, 130 nt probe L01761, 208 nt probe L01767, 219 nt probe L01847, 265 nt probe L01313, 411 nt probe L02201, 418 nt probe L01295, 450 nt probe L10626, and 458 nt probe L Version 14 (48) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. Version 13 (48) - Various textual changes. - The C18orf22 gene name changed into RBFA in Table 1. Version 12 (46) - Information about the Telomere Follow-up Set has been added. Version 11 (46) - Wrong gene name corrected (RIC8B to RIC8A). Version 10 (44) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. - Minor changes in the product description on page 1. - Several genes have a new name (HUGO gene name standardization) Version 09 (45) - Notes on the 5p, 12p, 16p, 17q, and 22q probes added in the important notes on specific telomers section. Version 08 (45) - Remark on page 6 about the old 4p probe in P070 Telomere has been removed. Version 07 (44) - Minor changes in the product description on page and the data analysis section on page 2. - Gene names in table 1 updated. Version 06 (43) - Table number added to Table 1. - Extra note added under Table 1 referring to the notes on p. 6 and 7 - Extra note added under Table 1 about probes for acrocentric chromosomes - Note on 12q (ZNF10) probe added on p Table about MLPA follow-up mixes updated - Text Finding the cause of mental retardation made more concise - Text on data analysis has been clarified by using slightly different wording - Various minor textual changes on page 1, various minor layout changes. SALSA P036 Human telomere-3 Page 9 of 9

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced.

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced. SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced. MENTAL RETARDATION is caused by aberrant copy numbers of subtelomeric

More information

MRC-Holland MLPA. Description version 08; 30 March 2015

MRC-Holland MLPA. Description version 08; 30 March 2015 SALSA MLPA probemix P351-C1 / P352-D1 PKD1-PKD2 P351-C1 lot C1-0914: as compared to the previous version B2 lot B2-0511 one target probe has been removed and three reference probes have been replaced.

More information

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B1-0613. The purpose of the P372 probemix is to further investigate results found with the P245 Microdeletion Syndromes-1A probemix. The

More information

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted. mix P169-C2 HIRSCHSPRUNG-1 Lot C2-0915. As compared to version C1 (lot C1-0612), the length of one has been adjusted. Hirschsprung disease (HSCR), or aganglionic megacolon, is a congenital disorder characterised

More information

MRC-Holland MLPA. Description version 12; 13 January 2017

MRC-Holland MLPA. Description version 12; 13 January 2017 SALSA MLPA probemix P219-B3 PAX6 Lot B3-0915: Compared to version B2 (lot B2-1111) two reference probes have been replaced and one additional reference probe has been added. In addition, one flanking probe

More information

MRC-Holland MLPA. Description version 14; 28 September 2016

MRC-Holland MLPA. Description version 14; 28 September 2016 SALSA MLPA probemix P279-B3 CACNA1A Lot B3-0816. As compared to version B2 (lot B2-1012), one reference probe has been replaced and the length of several probes has been adjusted. Voltage-dependent calcium

More information

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment). SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning:

More information

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 mix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 The purpose of the P371 mix is to further investigate results found with the P245 Microdeletion mix. The P245 mix provides a possibility to screen samples

More information

MRC-Holland MLPA. Description version 08; 18 November 2016

MRC-Holland MLPA. Description version 08; 18 November 2016 SALSA MLPA probemix P122-D1 NF1 AREA Lot D1-1016. As compared to lot C2-0312, four probes in the NF1 area and one reference probe have been removed, four reference probes have been replaced and several

More information

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 30; 06 June 2017 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are

More information

MRC-Holland MLPA. Description version 29; 31 July 2015

MRC-Holland MLPA. Description version 29; 31 July 2015 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082

More information

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced. mix P241-D2 MODY mix 1 Lot D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent diabetes

More information

MRC-Holland MLPA. Description version 07; 26 November 2015

MRC-Holland MLPA. Description version 07; 26 November 2015 SALSA MLPA probemix P266-B1 CLCNKB Lot B1-0415, B1-0911. As compared to version A1 (lot A1-0908), one target probe for CLCNKB (exon 11) has been replaced. In addition, one reference probe has been replaced

More information

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced. mix P241-D2 MODY mix 1 Lot D2-0716, D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent

More information

SALSA MLPA probemix P315-B1 EGFR

SALSA MLPA probemix P315-B1 EGFR SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional

More information

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix. SALSA MLPA KIT P045-B2 BRCA2/CHEK2 Lot 0410, 0609. As compared to version B1, four reference probes have been replaced and extra control fragments at 100 and 105 nt (X/Y specific) have been included. New:

More information

MRC-Holland MLPA. Description version 18; 09 September 2015

MRC-Holland MLPA. Description version 18; 09 September 2015 SALSA MLPA probemix P090-A4 BRCA2 Lot A4-0715, A4-0714, A4-0314, A4-0813, A4-0712: Compared to lot A3-0710, the 88 and 96 nt control fragments have been replaced (QDX2). This product is identical to the

More information

MRC-Holland MLPA. Description version 19;

MRC-Holland MLPA. Description version 19; SALSA MLPA probemix P6-B2 SMA Lot B2-712, B2-312, B2-111, B2-511: As compared to the previous version B1 (lot B1-11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). SPINAL

More information

P323-B1 CDK4-HMGA2-MDM2

P323-B1 CDK4-HMGA2-MDM2 SALSA MLPA probemix P323-B1 CDK4-HMGA2-MDM2 Lot B1-0714, B1-0711. As compared to previous test version (lot A1-0508), this probemix has been completely redesigned. Probes for HMGA2 and several other genes

More information

MRC-Holland MLPA. Description version 06; 23 December 2016

MRC-Holland MLPA. Description version 06; 23 December 2016 SALSA MLPA probemix P417-B2 BAP1 Lot B2-1216. As compared to version B1 (lot B1-0215), two reference probes have been added and two target probes have a minor change in length. The BAP1 (BRCA1 associated

More information

MRC-Holland MLPA. Description version 08; 07 May 2015

MRC-Holland MLPA. Description version 08; 07 May 2015 mix P185-C1 Intersex Lot C1-0611: As compared to the previous version B2 (lot B2-0311), s for CYP21A2 have been removed and s for the CXorf21 gene as well as additional s for NR0B1, NR5A1 and the Y chromosome

More information

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted. mix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four s have been adjusted. The sex-determining region on chromosome Y (SRY) is the most important

More information

SALSA MLPA KIT P060-B2 SMA

SALSA MLPA KIT P060-B2 SMA SALSA MLPA KIT P6-B2 SMA Lot 111, 511: As compared to the previous version B1 (lot 11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). Please note that, in contrast to the

More information

MRC-Holland MLPA. Description version 13;

MRC-Holland MLPA. Description version 13; SALSA MLPA probemix P027-C1 Uveal Melanoma Lot C1-0211: A large number of probes have been replaced by other probes in the same chromosomal regions as compared to previous lots, and several reference probes

More information

MRC-Holland MLPA. Description version 29;

MRC-Holland MLPA. Description version 29; SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,

More information

SALSA MLPA KIT P050-B2 CAH

SALSA MLPA KIT P050-B2 CAH SALSA MLPA KIT P050-B2 CAH Lot 0510, 0909, 0408: Compared to lot 0107, extra control fragments have been added at 88, 96, 100 and 105 nt. The 274 nt probe gives a higher signal in lot 0510 compared to

More information

MRC-Holland MLPA. Description version 06; 07 August 2015

MRC-Holland MLPA. Description version 06; 07 August 2015 SALSA MLPA probemix P323-B1 CDK4-HMGA2-MDM2 Lot B1-0711. As compared to version A1 (test version sent to test labs), this product has been completely redesigned. Probes for HMGA2 and several other genes

More information

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A1-1011. This SALSA MLPA probemix is for basic research and intended for experienced MLPA users only! This probemix enables you to quantify genes

More information

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53. SALSA MLPA probemix P056-C1 TP53 Lot C1-0215 & lot C1-0214. As compared to version B1 (lot B1-1011) most of the reference and flanking probes have been replaced and several have been added. Furthermore,

More information

PRADER WILLI/ANGELMAN

PRADER WILLI/ANGELMAN SALSA MS-MLPA probemix ME028-B2 PRADER WILLI/ANGELMAN Lot B2-0811: As compared to version B1 (lot B1-0609, B1-1108), the 88 and 96 nt control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME

More information

MRC-Holland MLPA. Description version 52; 22 July 2015

MRC-Holland MLPA. Description version 52; 22 July 2015 SALSA MS-MLPA probemix ME028-B2 Prader-Willi/Angelman Lot B2-0413, lot B2-0811. As compared to version B1 (lot B1-0609), the control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME (PWS) and

More information

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109 This P078-B1 Breast Tumour probemix contains probes for several genes (including ERBB2, BIRC5, MYC, TOP2A, ESR1, MTDH, CCND1, CCNE1, EGFR and C11orf30)

More information

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 The Mismatch Repair (MMR) system is critical for the maintenance of genomic stability. MMR increases the fidelity of DNA

More information

SALSA MLPA probemix P383-A1 T-ALL Lot A

SALSA MLPA probemix P383-A1 T-ALL Lot A SALSA MLPA probemix P383-A1 T-ALL Lot A1-0213. T-lineage acute lymphoblastic leukaemia (T-ALL) is a clonal malignant disorder of immature T-cells, which accounts for about 15% of paediatric and 25% of

More information

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B1-0916 and B1-0713. Copy number changes of the human chromosome 8 are common in many types of tumours. In most cases, losses of 8p sequences and gains of 8q

More information

MRC-Holland MLPA. Description version 23; 15 February 2018

MRC-Holland MLPA. Description version 23; 15 February 2018 SALSA MLPA probemix P225-D2 PTEN Lot D2-0315. As compared to the previous version (lot D1-0613), one probe has a small change in length but no change in the sequence detected. PTEN is a tumour suppressor

More information

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. This SALSA probemix is for basic research only! This

More information

MRC-Holland MLPA. Description version 05; 03 April 2019

MRC-Holland MLPA. Description version 05; 03 April 2019 SALSA MLPA probemix ME012-A1 MGMT-IDH1-IDH2 Lot A1-1215. Glioblastoma, the most common malignant primary brain tumour, is characterised by aggressive behaviour and a poor survival. Hypermethylation in

More information

MRC-Holland MLPA. Description version 24;

MRC-Holland MLPA. Description version 24; SALSA MLPA KIT P245-A2 Microdeletion Syndromes-1 Lot 0909, 0209, 1008. As compared to lot 1207, two extra control fragments at 100 and 105 nt have been added (X and Y-specific). The 108 nt Y probe has

More information

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol. Product Description SALSA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol. Version C2. As compared to version C1, three reference probes have been replaced and the lengths of

More information

MRC-Holland MLPA. Description version 28; 4 January 2018

MRC-Holland MLPA. Description version 28; 4 January 2018 SALSA MLPA probemix ME011-B3 Mismatch Repair genes Lot B3-1017 and B3-0715. As compared to the previous version B2 (lot B2-0614), one probe has a small change in length but no change in the sequence detected.

More information

MRC-Holland MLPA. Description version 10; 06 April 2018

MRC-Holland MLPA. Description version 10; 06 April 2018 Description version ; 6 April 8 mix P36-B Y-Chromosome Microdeletions Lot B-5. As compared to version A (Lot A-), all probes f DPY9L, one probe f RBMYCP and one probe f KDM5D have been removed, and one

More information

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Version C1. For complete product history see page 9. Catalogue numbers: ME028-025R: SALSA

More information

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol. Product Description SALSA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol. Version C1. For complete product history see page 7. Catalogue numbers: P138-025R: SALSA MLPA probemix

More information

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Product Description SALSA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Version C1. As compared to version B3, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19

More information

MRC-Holland MLPA. Description version 23; 26 January 2017

MRC-Holland MLPA. Description version 23; 26 January 2017 SALSA MLPA probemix ME024-B2 9p21 CDKN2A/2B region Lot B2-0615. As compared to the previous version B1 (lot B1-0411), one flanking probe is redesigned, two reference probes are replaced, and several probes

More information

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014 Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical

More information

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol. Product Description SALSA Probemix P055-D1 PAH To be used with the MLPA General Protocol. Version D1. For complete product history see page 7. Catalogue numbers: P055-025R: SALSA MLPA probemix P055 PAH,

More information

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Product Description SALSA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Version C2. Small change in sequence of two probes. For complete product history see page

More information

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol. Version F2. Compared to version F1, two reference probes have been replaced and the 118 nt Y fragment has been

More information

Certificate of Analysis

Certificate of Analysis COA Version 01; Issued on 30 June 2017 (v02) Certificate of Analysis SALSA probemix P064 Microdeletion Syndromes-1B Catalogue # Product name P064-025R, P064-50R, P064-100R Probemix P064 Microdeletion Syndromes-1B

More information

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه

More information

Children s Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia.

Children s Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia. Multiplex ligation-dependent probe amplification (MLPA) genetic testing in the diagnostics of children with developmental delay/intellectual disabilities Leona Morožin Pohovski, Ingeborg Barišid Children

More information

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol. Version C1. As compared to the previous version (lot B3-1017), this probemix has been

More information

Sharan Goobie, MD, MSc, FRCPC

Sharan Goobie, MD, MSc, FRCPC Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

Prenatal Diagnosis: Are There Microarrays in Your Future?

Prenatal Diagnosis: Are There Microarrays in Your Future? Financial Disclosure UCSF Antepartum Intrapartum Management Course June 8 I have no financial relationship with any aspect of private industry Prenatal Diagnosis: Are There Microarrays in Your Future?

More information

Genomic imbalance in subjects with idiopathic intellectual disability detected by multiplex ligation-dependent probe amplification

Genomic imbalance in subjects with idiopathic intellectual disability detected by multiplex ligation-dependent probe amplification c Indian Academy of Sciences RESEARCH NOTE Genomic imbalance in subjects with idiopathic intellectual disability detected by multiplex ligation-dependent probe amplification SHRUTHI MOHAN, VETTRISELVI

More information

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD

Approach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,

More information

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol. Version C1. As compared to version B3, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19

More information

Chromosome Structure & Recombination

Chromosome Structure & Recombination Chromosome Structure & Recombination (CHAPTER 8- Brooker Text) April 4 & 9, 2007 BIO 184 Dr. Tom Peavy Genetic variation refers to differences between members of the same species or those of different

More information

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads

New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads Susan Gross, MD Division of Reproductive Genetics Professor

More information

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol. Product Description SALSA Probemix P250-B2 DiGeorge To be used with the MLPA ral Protocol. Version B2. As compared to version B1, the control fragments have been adjusted. For complete product history

More information

Determination of Genomic Imbalances by Genome-wide Screening Approaches

Determination of Genomic Imbalances by Genome-wide Screening Approaches Overview Determination of Genomic Imbalances by Genome-wide Screening Approaches Károly Szuhai Introduction/Methodologies Applications/Results Conclusion Approaches Introduction/Methodologies Chromosome

More information

CYTOGENETICS Dr. Mary Ann Perle

CYTOGENETICS Dr. Mary Ann Perle CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,

More information

A. Incorrect! All the cells have the same set of genes. (D)Because different types of cells have different types of transcriptional factors.

A. Incorrect! All the cells have the same set of genes. (D)Because different types of cells have different types of transcriptional factors. Genetics - Problem Drill 21: Cytogenetics and Chromosomal Mutation No. 1 of 10 1. Why do some cells express one set of genes while other cells express a different set of genes during development? (A) Because

More information

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these

More information

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology

Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:

More information

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.

More information

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi 2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000

More information

Role of FISH in Hematological Cancers

Role of FISH in Hematological Cancers Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk

More information

Case 1B. 46,XY,-14,+t(14;21)

Case 1B. 46,XY,-14,+t(14;21) Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short

More information

MLPA SAMPLES USER GUIDE

MLPA SAMPLES USER GUIDE MLPA SAMPLES USER GUIDE MLPA microdeletion studies Requirements: 1-2 mls (minimum) of peripheral blood in a lithium heparin tube (green or orange top) AND 1-2 mls of peripheral blood in a EDTA tube (purple

More information

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Product Description SALSA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Version D1. As compared to version C2, 12 extra BRCA1 probes and 3 probes for exon 24 have been included, and

More information

Chromosome Abnormalities

Chromosome Abnormalities Chromosome Abnormalities Chromosomal abnormalities vs. molecular mutations Simply a matter of size Chromosomal abnormalities are big errors Two types of abnormalities 1. Constitutional problem present

More information

MOLECULAR MECHANISMS FOR CONSTITUTIONAL CHROMOSOMAL REARRANGEMENTS IN HUMANS

MOLECULAR MECHANISMS FOR CONSTITUTIONAL CHROMOSOMAL REARRANGEMENTS IN HUMANS Annu. Rev. Genet. 2000. 34:297 329 Copyright c 2000 by Annual Reviews. All rights reserved MOLECULAR MECHANISMS FOR CONSTITUTIONAL CHROMOSOMAL REARRANGEMENTS IN HUMANS Lisa G. Shaffer 1 and James R. Lupski

More information

Clinical evaluation of microarray data

Clinical evaluation of microarray data Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray

More information

Structural Variation and Medical Genomics

Structural Variation and Medical Genomics Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,

More information

Structural Chromosome Aberrations

Structural Chromosome Aberrations Structural Chromosome Aberrations 2 Structural chromosome aberrations or chromosome mutations represent apart from aneuploidies the most frequent pathologic findings in applied chromosome diagnostics.

More information

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic

More information

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Product Description SALSA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol. Version D1. For a complete product history see page 11. Catalogue numbers: P002-025R: SALSA MLPA probemix P002

More information

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Clinical Genomics. Ina E. Amarillo, PhD FACMGG Clinical Genomics Ina E. Amarillo, PhD FACMGG Associate Medical Director, Cytogenetics Lab (CaTG), Lab and Genomic Medicine Assistant Professor, Pathology and Immunology Outline Clinical Genomics Testing

More information

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 Why causation? Explanation for family Prognosis Recurrence risk and reproductive options Guide medical

More information

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)

22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) 22q11.2 DELETION SYNDROME Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) Genomic disorders GENOMICS DISORDERS refers to those diseases

More information

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our 1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented

More information

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics

More information

MODULE NO.14: Y-Chromosome Testing

MODULE NO.14: Y-Chromosome Testing SUBJECT Paper No. and Title Module No. and Title Module Tag FORENSIC SIENCE PAPER No.13: DNA Forensics MODULE No.21: Y-Chromosome Testing FSC_P13_M21 TABLE OF CONTENTS 1. Learning Outcome 2. Introduction:

More information

scfish: A Primer Peter K. Rogan, Ph.D. Joan H. M. Knoll, Ph.D., FACMG, FCCMG Children s Mercy Hospitals and Clinics Tuesday, July 29, 2003

scfish: A Primer Peter K. Rogan, Ph.D. Joan H. M. Knoll, Ph.D., FACMG, FCCMG Children s Mercy Hospitals and Clinics Tuesday, July 29, 2003 scfish: A Primer Peter K. Rogan, Ph.D. Joan H. M. Knoll, Ph.D., FACMG, FCCMG Children s Mercy Hospitals and Clinics Tuesday, July 29, 2003 FISH: A Molecular Cytogenetic Test Complementary nucleic acid

More information

Genetic Testing 101: Interpreting the Chromosomes

Genetic Testing 101: Interpreting the Chromosomes Genetic Testing 101: Interpreting the Chromosomes Kristin Lindstrom, MD Division of Genetics and Metabolism Phoenix Children s Hospital AzAAP Pediatrics in the Red Rocks I have no disclosures for this

More information

Variations in Chromosome Structure & Function. Ch. 8

Variations in Chromosome Structure & Function. Ch. 8 Variations in Chromosome Structure & Function Ch. 8 1 INTRODUCTION! Genetic variation refers to differences between members of the same species or those of different species Allelic variations are due

More information

Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation

Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation Pediatr Neonatol 2008;49(6):213 217 REVIEW ARTICLE Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation Jao-Shwann Liang 1,2 *, Keiko Shimojima

More information

Understanding The Genetics of Diamond Blackfan Anemia

Understanding The Genetics of Diamond Blackfan Anemia Understanding The Genetics of Diamond Blackfan Anemia Jason Farrar, MD jefarrar@ About Me Assistant Professor of Pediatrics at University of Arkansas for Medical Sciences & Arkansas Children s Hospital

More information

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter

More information

Microdeletion and Prenatal FISH Probes

Microdeletion and Prenatal FISH Probes Microdeletion and Prenatal FISH Probes Rapid Prenatal Screening The Cytocell prenatal FISH assays are designed for the rapid and accurate detection of the most common foetal chromosomal disorders: Down

More information

Introduction to genetic variation. He Zhang Bioinformatics Core Facility 6/22/2016

Introduction to genetic variation. He Zhang Bioinformatics Core Facility 6/22/2016 Introduction to genetic variation He Zhang Bioinformatics Core Facility 6/22/2016 Outline Basic concepts of genetic variation Genetic variation in human populations Variation and genetic disorders Databases

More information

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits?

5/2/18. After this class students should be able to: Stephanie Moon, Ph.D. - GWAS. How do we distinguish Mendelian from non-mendelian traits? corebio II - genetics: WED 25 April 2018. 2018 Stephanie Moon, Ph.D. - GWAS After this class students should be able to: 1. Compare and contrast methods used to discover the genetic basis of traits or

More information

A 9-YEAR-OLD-GIRL WITH PHELAN McDERMID SYNDROME, WHO HAD BEEN DIAGNOSED WITH AN AUTISM SPECTRUM DISORDER

A 9-YEAR-OLD-GIRL WITH PHELAN McDERMID SYNDROME, WHO HAD BEEN DIAGNOSED WITH AN AUTISM SPECTRUM DISORDER 19 (2), 2016 85-90 DOI: 10.1515/bjmg-2016-0041 case report A 9-YEAR-OLD-GIRL WITH PHELAN McDERMID SYNDROME, WHO HAD BEEN DIAGNOSED WITH AN AUTISM SPECTRUM DISORDER Görker I 1,*, Gürkan H 2, Demir Ulusal

More information